Whittier Trust CO Of Nevada Inc Catalent, Inc. Transaction History

Whittier Trust CO Of Nevada Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$53.58 - $57.02 $160 - $171	3 New	3 $0
Q3 2023 Oct 27, 2023	BUY	$44.2 - $50.2 $176 - $200	4 New	4 $0
Q1 2023 Apr 21, 2023	BUY	$45.44 - $74.26 $772 - $1,262	17 New	17 $1,000
Q4 2021 Jan 19, 2022	SELL	$119.57 - $139.07 $35,871 - $41,721	-300 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$109.17 - $142.35 $32,751 - $42,705	300 New	300 $40,000

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.